SCHEMBL3333732

SCHEMBL3333732

CCC(C)OBOC(C)CC

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1270908 0.75
SCHEMBL4305177 0.75
SCHEMBL19821973 0.71
SCHEMBL27628178 0.69
SCHEMBL22096628 0.68
SCHEMBL147241 0.67
SCHEMBL515418 0.67 TSHR (0.38) TSHR
SCHEMBL5791362 0.67
SCHEMBL14000783 0.67
SCHEMBL1126640 0.67 TSHR (0.32) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107778451-B Low-free high-hardness boron modified polyurethane curing agent 合众(佛山)化工有限公司 2020-09-04 CN claimed
CN-111440366-A Specific boron-hybridized methyl vinyl MQ silicon resin and application thereof 湖南辰砾新材料有限公司 2020-07-24 CN claimed
CN-111410781-A Automobile tire 湖南辰砾新材料有限公司 2020-07-14 CN claimed
EP-3063154-B1 CROSS-COUPLING OF UNACTIVATED SECONDARY BORONIC ACIDS UNIV ILLINOIS (US) 2023-08-30 EP disclosed
CN-107778451-B Low-free high-hardness boron modified polyurethane curing agent 合众(佛山)化工有限公司 2020-09-04 CN disclosed
CN-107759860-B Rubber composition for tread of medium and large automobile tire 肇庆骏鸿实业有限公司 2020-09-04 CN disclosed
CN-111440366-A Specific boron-hybridized methyl vinyl MQ silicon resin and application thereof 湖南辰砾新材料有限公司 2020-07-24 CN disclosed
CN-111410781-A Automobile tire 湖南辰砾新材料有限公司 2020-07-14 CN disclosed
US-10072028-B2 Cross-coupling of unactivated secondary boronic acids THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2018-09-11 US disclosed
EP-3169662-B1 SUBSTITUTED VINYL- AND ALKINYL-CYANOCYCLOALKANOLS AND VINYL- AND ALKINYL-CYANOHETEROCYCLOALKANOLS AS AGENTS TO COMBAT ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2018-07-11 EP disclosed
EP-3172187-A1 SUBSTITUTED CYANO CYCLOALKYL PENTA-2,4-DIENES, CYANO CYCLOALKYL PENT-2-EN-4-YNES, CYANO HETEROCYCLYL PENTA-2,4-DIENES AND CYANO HETEROCYCLYL PENT-2-EN-4-YNES AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS Bayer CropScience Aktiengesellschaft (DE) 2017-05-31 EP disclosed
US-8610075-B2 Radioimaging applications of and novel formulations of teboroxime BIOSENSORS INTERNATIONAL GROUP LTD. (BM) 2013-12-17 US disclosed
US-8481946-B2 2013-07-09 US disclosed
US-20100140483-A1 RADIOIMAGING APPLICATIONS OF AND NOVEL FORMULATIONS OF TEBOROXIME Spectrum Dynamics Medical Limited (VG) 2010-06-10 US disclosed
WO-2008059489-A2 RADIOIMAGING APPLICATIONS OF AND NOVEL FORMULATIONS OF TEBOROXIME SPECTRUM DYNAMICS LLC (US) 2008-05-22 WO disclosed
EP-0199260-B1 BORONIC ACID ADDUCTS OF TECHNETIUM-99M DIOXIME COMPLEXES E.R. Squibb & Sons, Inc. (US) 1989-12-06 EP disclosed
US-4705849-A Boronic acid adducts of technetium-99m dioxime complexes E. R. SQUIBB & SONS, INC. (US) 1987-11-10 US disclosed
US-4634722-A CONTACT LENSES FROM PROTECTED ACRYLIC ESTER DERIVATIVES SYNTEX (U.S.A.) INC. (US) 1987-01-06 US disclosed
EP-0199260-A2 Boronic acid adducts of technetium-99M dioxime complexes E.R. Squibb & Sons, Inc. (US) 1986-10-29 EP disclosed
US-4401797-A ADDUCT OF DIHYDROXYPROPYL (METH)ACRYLATE AND BORONIC ACID SYNTEX (U.S.A.) INC. (US) 1983-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100140483-A1 RADIOIMAGING APPLICATIONS OF AND NOVEL FORMULATIONS OF TEBOROXIME TNNI3, TNNT2, IDO1 TSHR 254/4885
US-10072028-B2 Cross-coupling of unactivated secondary boronic acids BOLA2; BOLA2B, BLVRB, CD79B TSHR 2727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.